{"id":"https://openalex.org/W2139131914","doi":"https://doi.org/10.1186/1471-2407-9-142","title":"MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer","display_name":"MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer","publication_year":2009,"publication_date":"2009-05-11","ids":{"openalex":"https://openalex.org/W2139131914","doi":"https://doi.org/10.1186/1471-2407-9-142","mag":"2139131914","pmid":"https://pubmed.ncbi.nlm.nih.gov/19432987","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2685437"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2407-9-142","doi":"https://doi.org/10.1186/1471-2407-9-142","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-9-142","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-9-142","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-9-142","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039967240","display_name":"Wenqing Qi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Wenqing Qi","raw_affiliation_strings":["Arizona Cancer Center, the University of Arizona, Tucson, AZ 85724, USA. wenqing@email.arizona.edu","Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, the University of Arizona, Tucson, AZ 85724, USA. wenqing@email.arizona.edu","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]},{"raw_affiliation_string":"Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724, USA","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112801807","display_name":"Larry S. Cooke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry S Cooke","raw_affiliation_strings":["Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","Arizona Cancer Center, The University of Arizona,Tucson,USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Arizona Cancer Center, The University of Arizona,Tucson,USA","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Amy Stejskal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Stejskal","raw_affiliation_strings":["Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","Arizona Cancer Center, The University of Arizona,Tucson,USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Arizona Cancer Center, The University of Arizona,Tucson,USA","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061211643","display_name":"Christopher Riley","orcid":"https://orcid.org/0000-0001-7930-1495","observed_orcids":["https://orcid.org/0000-0001-7930-1495"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Riley","raw_affiliation_strings":["Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","Arizona Cancer Center, The University of Arizona,Tucson,USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Arizona Cancer Center, The University of Arizona,Tucson,USA","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033512976","display_name":"Kimiko Della Croce","orcid":"https://orcid.org/0000-0002-1596-3454","observed_orcids":["https://orcid.org/0000-0002-1596-3454"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimiko Della Croce","raw_affiliation_strings":["Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","Arizona Cancer Center, The University of Arizona,Tucson,USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Arizona Cancer Center, The University of Arizona,Tucson,USA","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068176108","display_name":"Jos\u00e9 W. Saldanha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jose W Saldanha","raw_affiliation_strings":["National Institute for Medical Research, Mill Hill, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute for Medical Research, Mill Hill, London, UK","institution_ids":["https://openalex.org/I4405285715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037979147","display_name":"David J. Bearss","orcid":"https://orcid.org/0000-0003-4940-9942","observed_orcids":["https://orcid.org/0000-0003-4940-9942"]},"institutions":[{"id":"https://openalex.org/I4210149223","display_name":"SuperGen (United States)","ror":"https://ror.org/049922318","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210149223","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Bearss","raw_affiliation_strings":["SuperGen, Inc, Dublin, CA, 94568, USA","SuperGen, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SuperGen, Inc, Dublin, CA, 94568, USA","institution_ids":["https://openalex.org/I4210149223"]},{"raw_affiliation_string":"SuperGen, Inc","institution_ids":["https://openalex.org/I4210149223"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101638085","display_name":"Daruka Mahadevan","orcid":"https://orcid.org/0000-0002-7129-5593","observed_orcids":["https://orcid.org/0000-0002-7129-5593"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daruka Mahadevan","raw_affiliation_strings":["Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","Arizona Cancer Center, The University of Arizona,Tucson,USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arizona Cancer Center, the University of Arizona, Tucson, AZ, 85724, USA","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"Arizona Cancer Center, The University of Arizona,Tucson,USA","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5039967240","https://openalex.org/A5101638085"],"corresponding_institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":6.7142,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.97119827,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":"1","first_page":"142","last_page":"142"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.8709999918937683},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/erbb-receptors","display_name":"ErbB receptors","score":0.7889999747276306},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9290000200271606},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8349999785423279},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8939999938011169},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.6179999709129333},{"id":"https://openalex.org/keywords/lncap-xenografts","display_name":"LNCaP xenografts","score":0.8560000061988831},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.921999990940094}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8223358392715454},{"id":"https://openalex.org/C2780140570","wikidata":"https://www.wikidata.org/wiki/Q3545481","display_name":"Surgical oncology","level":2,"score":0.7110961675643921},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6702171564102173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6271735429763794},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5533435940742493},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5362585783004761},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5340349674224854},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.524176299571991},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5048819184303284},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4878668785095215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38926130533218384},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38468050956726074},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3320525288581848},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.300605833530426},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2821452021598816},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.22684118151664734},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1963495910167694},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.08300566673278809}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005810","descriptor_name":"Multigene Family","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013890","descriptor_name":"Thiourea","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020794","descriptor_name":"Receptor Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020794","descriptor_name":"Receptor Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1186/1471-2407-9-142","doi":"https://doi.org/10.1186/1471-2407-9-142","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-9-142","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-9-142","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2685437","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2685437","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"Text"},{"id":"pmid:19432987","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19432987","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC cancer","raw_type":"Journal Article"},{"id":"pmh:oai:repository.arizona.edu:10150/610342","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10150/610342","pdf_url":null,"source":{"id":"https://openalex.org/S4306400271","display_name":"UA Campus Repository (The University of Arizona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138006243","host_organization_name":"University of Arizona","host_organization_lineage":["https://openalex.org/I138006243"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.786.4128","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.786.4128","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/01/14/1471-2407-9-142.PMC2685437.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:559aec17a2ba47a2ac50607f370c3472","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/559aec17a2ba47a2ac50607f370c3472","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Cancer, Vol 9, Iss 1, p 142 (2009)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1471-2407-9-142","doi":"https://doi.org/10.1186/1471-2407-9-142","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2407-9-142","pdf_url":"https://bmccancer.biomedcentral.com/counter/pdf/10.1186/1471-2407-9-142","source":{"id":"https://openalex.org/S192926780","display_name":"BMC Cancer","issn_l":"1471-2407","issn":["1471-2407"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309707","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/03m2x1q45"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139131914.pdf","grobid_xml":"https://content.openalex.org/works/W2139131914.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W57208077","https://openalex.org/W60390279","https://openalex.org/W1562110281","https://openalex.org/W1673408032","https://openalex.org/W1787826185","https://openalex.org/W1965734230","https://openalex.org/W1966268953","https://openalex.org/W1969022943","https://openalex.org/W1980006154","https://openalex.org/W1987079567","https://openalex.org/W1988851851","https://openalex.org/W1991287336","https://openalex.org/W1998971866","https://openalex.org/W2003852222","https://openalex.org/W2004542452","https://openalex.org/W2010309554","https://openalex.org/W2012147443","https://openalex.org/W2012865220","https://openalex.org/W2017362326","https://openalex.org/W2022743869","https://openalex.org/W2025288244","https://openalex.org/W2025319771","https://openalex.org/W2028415754","https://openalex.org/W2035606709","https://openalex.org/W2038846160","https://openalex.org/W2055519466","https://openalex.org/W2057477877","https://openalex.org/W2058112104","https://openalex.org/W2059817089","https://openalex.org/W2068393070","https://openalex.org/W2073051869","https://openalex.org/W2089381826","https://openalex.org/W2090802890","https://openalex.org/W2093371959","https://openalex.org/W2098326830","https://openalex.org/W2110350248","https://openalex.org/W2112501269","https://openalex.org/W2117812548","https://openalex.org/W2120292596","https://openalex.org/W2122764102","https://openalex.org/W2129129118","https://openalex.org/W2130840817","https://openalex.org/W2132315278","https://openalex.org/W2146012957","https://openalex.org/W2147907417","https://openalex.org/W2149470160","https://openalex.org/W2155228264","https://openalex.org/W2159400887","https://openalex.org/W2162931896","https://openalex.org/W2163634266","https://openalex.org/W2164452916","https://openalex.org/W4211075026"],"related_works":["https://openalex.org/W7097805423","https://openalex.org/W2740491586","https://openalex.org/W2121640179","https://openalex.org/W2144209831","https://openalex.org/W2047002642","https://openalex.org/W2140202848","https://openalex.org/W2161747380","https://openalex.org/W1972969589","https://openalex.org/W2500421313","https://openalex.org/W1983353948"],"abstract_inverted_index":{"BACKGROUND:":[0],"Prostate":[1],"cancer":[2,43,63,90,112,163],"is":[3,13],"a":[4,73,219,247],"common":[5],"disease":[6],"in":[7,41,61,81,91,94,107,161,183,218],"men":[8],"and":[9,34,45,59,93,117,132,171,209,244],"at":[10],"present":[11],"there":[12],"no":[14],"effective":[15],"therapy":[16],"available":[17],"due":[18],"to":[19,142,207],"its":[20],"recurrence":[21],"despite":[22],"androgen":[23,215],"deprivation":[24],"therapy.":[25],"The":[26,97,120],"epidermal":[27],"growth":[28,146,231],"factor":[29],"receptor":[30,75],"family":[31,196],"(EGFR/HER1,":[32],"HER2/neu":[33],"HER3)/PI3K/Akt":[35],"signaling":[36],"axis":[37],"has":[38,54,85],"been":[39],"implicated":[40],"prostate":[42,62,89,111,162,252],"development":[44],"progression.":[46],"However,":[47],"Erlotinib,":[48],"an":[49],"EGFR":[50],"tyrosine":[51,76],"kinase":[52,77],"inhibitor,":[53],"less":[55],"effect":[56,87],"on":[57,88,168],"proliferation":[58],"apoptosis":[60,118,174],"cell":[64,113,164],"lines.":[65,165],"In":[66],"this":[67],"study,":[68],"we":[69],"evaluate":[70],"whether":[71],"MP470,":[72,149],"novel":[74,248],"inhibitor":[78],"alone":[79],"or":[80,101,151],"combination":[82,153,184,188,226],"with":[83,181,185],"Erlotinib":[84,104,150],"inhibitory":[86],"vitro":[92,108],"vivo.":[95],"METHODS:":[96],"efficacy":[98],"of":[99,173,193,202],"MP470":[100,102,156,182],"plus":[103],"was":[105,124,139],"evaluated":[106],"using":[109],"three":[110],"lines":[114],"by":[115,127,148],"MTS":[116],"assays.":[119],"molecular":[121],"mechanism":[122],"study":[123],"carried":[125],"out":[126],"phosphorylation":[128,192],"antibody":[129],"array,":[130],"immunoblotting":[131],"immunohistochemistry.":[133],"A":[134],"LNCaP":[135,178,220],"mouse":[136,221],"xenograft":[137,222],"model":[138],"also":[140],"used":[141],"determine":[143],"the":[144,152,194,224,240],"tumor":[145,230],"inhibition":[147,232],"treatments.":[154],"RESULTS:":[155],"exhibits":[157],"low":[158],"microM":[159],"IC50":[160],"Additive":[166],"effects":[167],"both":[169],"cytotoxicity":[170],"induction":[172],"were":[175,179],"observed":[176],"when":[177],"treated":[180],"Erlotinib.":[186],"This":[187],"treatment":[189],"completely":[190],"inhibited":[191],"HER":[195,241],"members":[197],"(HER1,":[198],"2,":[199],"3),":[200],"binding":[201],"PI3K":[203],"regulatory":[204],"unit":[205],"p85":[206],"HER3":[208],"downstream":[210],"Akt":[211],"activity":[212],"even":[213],"after":[214],"depletion.":[216],"Furthermore,":[217],"model,":[223],"MP470-Erlotinib":[225,238],"produced":[227],"30-65%":[228],"dose-dependent":[229],"(TGI).":[233],"CONCLUSION:":[234],"We":[235],"propose":[236],"that":[237],"targets":[239],"family/PI3K/Akt":[242],"pathway":[243],"may":[245],"represent":[246],"therapeutic":[249],"strategy":[250],"for":[251],"cancer.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}